UBS Maintains Buy on UnitedHealth Group, Lowers Price Target to $650

Benzinga · 10/16 15:54
UBS analyst Kevin Caliendo maintains UnitedHealth Group (NYSE:UNH) with a Buy and lowers the price target from $680 to $650.